User profiles for Fareed Khawaja
Fareed KhawajaMD Anderson Cancer Center Verified email at mdanderson.org Cited by 375 |
Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control
Objectives:Prolonged survival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
on environmental surfaces and personal protective equipment may lead to these …
on environmental surfaces and personal protective equipment may lead to these …
Refractory and resistant cytomegalovirus after hematopoietic cell transplant in the letermovir primary prophylaxis era
Background Cytomegalovirus (CMV) reactivation is one of the most common infectious
complications after allogeneic hematopoietic cell transplant (HCT) and may result in significant …
complications after allogeneic hematopoietic cell transplant (HCT) and may result in significant …
[HTML][HTML] Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium
… Author links open overlay panel Fareed Khawaja 1 , Amy Spallone 1 , Camille N. Kotton 2
, … Fareed Khawaja has no conflicts of interest to declare. Amy Spallone has no conflicts of …
, … Fareed Khawaja has no conflicts of interest to declare. Amy Spallone has no conflicts of …
[HTML][HTML] Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
F Khawaja, RF Chemaly - Haematologica, 2019 - ncbi.nlm.nih.gov
In the USA and other western nations, respiratory syncytial virus is one of the most
commonly encountered respiratory viruses among patients who have been diagnosed with a …
commonly encountered respiratory viruses among patients who have been diagnosed with a …
Incidence and risk factors for pneumonitis associated with checkpoint inhibitors in advanced non-small cell lung cancer: a single center experience
…, AA Vaporciyan, K Jennings, F Khawaja… - The …, 2023 - academic.oup.com
… Fareed Khawaja reported honorarium from Merck and personal fees from MEDSCAPE
outside of the submitted work. NG reported research funding (to institution) from Daiichi-Sankyo, …
outside of the submitted work. NG reported research funding (to institution) from Daiichi-Sankyo, …
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Background: An increasing number of observational studies have reported the persistence
of symptoms following recovery from acute COVID-19 disease in non-cancer patients. The …
of symptoms following recovery from acute COVID-19 disease in non-cancer patients. The …
Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study
…, PV Chin-Hong, E Benamu, F Khawaja… - Clinical Infectious …, 2024 - academic.oup.com
Background Pneumonia is a common cause of morbidity and mortality, yet a causative
pathogen is identified in a minority of cases. Plasma microbial cell-free DNA sequencing may …
pathogen is identified in a minority of cases. Plasma microbial cell-free DNA sequencing may …
Coronavirus disease-2019 in the immunocompromised host
CD Bertini, F Khawaja… - Clinics in Chest …, 2023 - chestmed.theclinics.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory virus that
originated in Wuhan, China in 2019. Since that time, SARS-CoV-2 has been responsible for …
originated in Wuhan, China in 2019. Since that time, SARS-CoV-2 has been responsible for …
[HTML][HTML] Frequently asked questions on coronavirus disease 2019 vaccination for hematopoietic cell transplantation and chimeric antigen receptor T-cell recipients …
F Khawaja, G Papanicolaou, S Dadwal… - … and cellular therapy, 2023 - Elsevier
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised and elderly patients…
coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised and elderly patients…
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
Background Immune checkpoint inhibitors (ICI), combined with hypomethylating agents,
can be used to treat acute myeloid leukemia (AML), but this strategy results in a high rate of …
can be used to treat acute myeloid leukemia (AML), but this strategy results in a high rate of …